Liftstream is an executive search recruitment company in the life sciences sector
Kiadis rides high after positive clinical data
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged 4SC, acute lymphoblastic leukaemia, Acute Myeloid Leukaemia, ALL, Alta Partners, AML, Amsterdam Biotech, ATIR, Cardion, clinical data, Dr Manfred Rudiger, Dutch, Esprit Capital, haematology, holland, Igenon, Kiadis, Life Science Partners, MDS, MedSciences Capital, myelodysplastic syndome, oncology, Orphan Drug, phase II study, t2cure
Leave a comment
ERYTECH makes new appointment to Board of Directors
Authored by Karl Simpson
Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged acute lymphoblastic leukaemia, Acute Myeloid Leukaemia, ALL, AML, Cancer Bio-Sante, ERYTECH, europe, France, GRASPA, Ipsen, Israel, Kurma Ventures, Orphan Europe, Paris, Recordati, Teva, Vanessa Mailer, venture capital
Leave a comment
Jazz Pharmaceuticals to acquire rare disease company Gentium
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Acute Lymphoblastic Leukemia, ALL, Azur Pharma, Bruce Cozadd, Defitelio, Dublin, EMA, Erwinase, EU, EUSA Pharma, FDA, Gentium, Graft vs Host Disease, GvHD, Ireland, Italy, Jazz Pharmaceuticals, Khalid Islam, M&A, Orphan drugs, Rare Disease, regulatory approval, severe hepatic veno-occlusive disease, VOD
2 Comments